Psyence Biomedical (NASDAQ: PBM) invested an additional $500,000 in PsyLabs, deepening its relationship with the psychedelic ingredients producer while securing exclusive access to pharmaceutical-grade ibogaine. The cash infusion builds on Psyence’s initial partnership from September 2024, when it acquired an 11.13% equity stake in PsyLabs and locked down exclusive rights …
Tag: Investing
Grown Rogue posts strong early results from ABCO Garden State
Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) announced that its New Jersey cannabis cultivation affiliate generated $1.8 million in preliminary first-quarter revenue with gross margins between 55% and 60%, showing some early success in the Garden State market. The Oregon-based craft cannabis company provided some details on both the …
Recreational cannabis continues to fuel Ohio sales numbers
This story was republished with permission from Crain’s Cleveland Business. Ohio’s legal cannabis industry has generated $656.4 million in marijuana sales in the eight months since the state’s adult-use program launched in early August. That figure represents retail sales recorded by the Ohio Division of Cannabis Control from Aug. 6, …
Hemp beverages beat craft beers when it comes to tariffs
President Donald Trump’s on again, off again tariffs have rattled many industries, including the regulated cannabis industry that will be affected as vape hardware and packaging prices get hit with tariffs in shipments from Asia. But according to a new report from Whitney Economics, one segment could actually benefit: hemp …